Lonza gets licence to make ingredients for Moderna vaccine
By John MillerZURICH, March 15 (Reuters) - Swiss contract drug manufacturer Lonza received a key licence from Switzerland to produce ingredients for...
By John MillerZURICH, March 15 (Reuters) - Swiss contract drug manufacturer Lonza received a key licence from Switzerland to produce ingredients for...